Healthcare • Medical Devices
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if NSPR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
8 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 7
36 filers reported a long position in NSPR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Rosalind Advisors, Inc. | $2.7M | 3.9M | Unchanged |
| Aberdeen Group plc | $2.6M | 3.7M | +16.5% |
| Nantahala Capital Management, LLC | $2.4M | 3.4M | Unchanged |
| ORBIMED ADVISORS LLC | $2.2M | 3.1M | Unchanged |
| Parkman Healthcare Partners LLC | $1.7M | 2.4M | Unchanged |
| MARSHALL WACE, LLP | $1.3M | 1.9M | Unchanged |
| Soleus Capital Management, L.P. | $732.1K | 1M | Unchanged |
| INGALLS & SNYDER LLC | $258K | 368.8K | -2.8% |
| Affiance Financial, LLC | $175.3K | 250.4K | Unchanged |
| Velan Capital Investment Management LP | $103.7K | 148.1K | -92.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.